Table 4.
Diagnosed Diabetes | ||||
---|---|---|---|---|
A1c <53 mmol/mol (<7.0%) (N = 1029) (Reference) | A1c 53-<75 mmol/mol (7.0% -<9.0%) (N = 730) | A1c 65-<97 mmol/mol (9.0% - <11.0%) (N = 217) | A1c ≥97 mmol/mol (≥11.0%) (N = 147) | |
Overall | 73 (0.7) | 74 (0.6) | 78 (1.1)b | 80 (1.4)b |
Age, y | ||||
20 to 44 | 78 (1.3) | 80 (1.8) | 85 (2.6)a | 82 (2.1) |
45 to 64 | 73 (0.9) | 76 (0.7)a | 77 (1.5)a | 80 (2.1)a |
≥ 65 | 71 (0.9) | 70 (0.9) | 73 (2.4) | 78 (1.6)b |
Sex | ||||
Men | 73 (0.8) | 73 (0.6) | 77 (1.8)a | 77 (1.9)a |
Women | 73 (0.8) | 76 (1.2)a | 79 (1.4)a | 84 (1.7)b |
Race/Ethnicity | ||||
All Hispanic | 72 (0.7) | 75 (0.8)a | 82 (1.8)b | 80 (1.9)b |
Mexican American | 72 (1.1) | 75 (1.2)a | 82 (2.0)b | 79 (2.3)a |
Non-Hispanic white | 74 (0.9) | 74 (0.9) | 78 (1.7)a | 78 (3.7) |
Non-Hispanic black | 72 (0.8) | 75 (1.0)a | 77 (2.9) | 82 (1.5)b |
Education | ||||
< High school | 72 (0.7) | 75 (1.0)a | 78 (1.6)a | 83 (1.8)b |
High school/GED | 73 (1.2) | 71 (1.3) | 79 (1.5)a | 75 (2.7) |
≥ High school | 73 (1.0) | 76 (0.9) | 77 (1.7)a | 82 (1.8)b |
PIR | ||||
≤ 1.00 | 75 (0.9) | 76 (1.2) | 79 (1.7)a | 81 (2.8) |
> 1.00 | 72 (0.7) | 74 (0.7)a | 78 (1.2)b | 81 (1.6)b |
Health insurance coverage | ||||
Yes | 73 (0.7) | 75 (0.6) | 77 (1.1)b | 79 (1.6)b |
No | 75 (1.3) | 73 (1.2) | 82 (2.3)a | 84 (1.8)a |
Smoking status | ||||
Current | 79 (2.4) | 77 (1.8) | 79 (2.8) | 79 (1.8) |
Former | 72 (1.1) | 73 (1.5) | 77 (2.1)a | 76 (3.0) |
Never | 72 (0.8) | 74 (0.8) | 78 (1.7)a | 83 (1.9)b |
Sleep, h | ||||
< 7 | 71 (0.9) | 75 (0.9)a | 78 (1.5)b | 79 (1.2)b |
≥ 7 | 73 (0.8) | 74 (1.0) | 78 (1.2)b | 81 (1.8)b |
Work time activity | ||||
Yes | 74 (0.7) | 73 (0.9) | 80 (2.3)a | 77 (1.9) |
No | 72 (0.9) | 75 (0.8)a | 76 (1.34)a | 82 (1.7)b |
Leisure time activity | ||||
Yes | 72 (0.8) | 75 (1.1) | 78 (2.3)a | 80 (2.3)b |
No | 73 (0.8) | 74 (0.6) | 78 (1.2)a | 81 (1.6)b |
BMI, kg/m2 | ||||
< 25.0 | 73 (2.3) | 73 (1.1) | 76 (4.4) | 80 (3.2) |
25.0–29.9 | 73 (0.9) | 73 (1.2) | 80 (1.7)b | 75 (2.9) |
≥ 30.0 | 73 (0.8) | 75 (0.8) | 78 (1.5)a | 83 (1.1)b |
Waist circumference | ||||
High risk (> 88 cm for women; >102 cm for men) | 73 (0.7) | 75 (0.8) | 78 (1.2)a | 82 (1.6)b |
Low risk (≤ 88 cm for women; ≤ 102 cm for men) | 72 (1.8) | 72 (1.1) | 80 (3.4) | 77 (2.9) |
Hypertension, self-report | ||||
Yes | 73 (0.9) | 75 (0.8) | 77 (1.4)a | 80 (1.9)a |
No | 72 (0.8) | 74 (1.1) | 79 (1.6)b | 81 (1.7)b |
History of CVD | ||||
Yes | 67 (1.1) | 69 (1.0) | 72 (3.1) | 75 (4.5) |
No | 74 (0.7) | 76 (0.6) | 79 (1.0)b | 81 (1.2)b |
eGFR, mL/min per 1.73 m2 | ||||
< 60 | 70 (1.3) | 72 (1.5) | 74 (2.0) | 83 (2.8)b |
≥ 60 | 74 (0.8) | 75 (0.7) | 78 (1.23)b | 80 (1.7)a |
ACE inhibitor or ARB | ||||
Yes | 73 (0.9) | 74 (0.8) | 76 (1.4) | 81 (2.3)a |
No | 72 (0.8) | 74 (1.0) | 80 (1.5)b | 80 (1.4)b |
β-blockers | ||||
Yes | 68 (0.7) | 68 (1.2) | 73 (2.4)a | 79 (4.5)a |
No | 75 (0.8) | 77 (0.7)a | 79 (1.1)b | 81 (1.1)b |
Diuretics | ||||
Yes | 73 (1.2) | 74 (1.2) | 76 (1.7) | 79 (2.5)a |
No | 73 (0.7) | 74 (0.6)a | 78 (1.3)b | 81 (1.7)b |
CA-channel blockers | ||||
Yes | 73 (1.7) | 73 (1.0) | 78 (2.7) | 80 (4.8) |
No | 73 (0.7) | 75 (0.8) | 78 (1.1)b | 80 (1.1)b |
Taking statin | ||||
Yes | 72 (1.0) | 73 (0.7) | 73 (1.8) | 78 (2.6)a |
No | 74 (0.8) | 76 (1.0)a | 82 (1.2)b | 82 (1.6)b |
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; CA, calcium; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; GED, General Educational Development; HbA1c, hemoglobin A1c; NHANES, National Health and Nutrition Examination Survey, PIR, poverty income ratio.
a P less than .05 vs HbA1c less than 7.0%.
b P less than .001 vs HbA1c less than 7.0%.